The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...

A panelist discusses how second-line treatment options for kidney cancer have evolved through multiple clinical trials ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Steve Lyles has been fighting crime with the sheriff's department for nearly 20 years. For the past five, he's been fighting ...

Katy Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose modifications for patients with RCC.

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

NSAID use is associated with an increased risk of death from RCC among women but not among men, researchers found.

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...